MedTrace Logo

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain

NCT04662905 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-05-19

No results posted yet for this study

Summary

The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.

Conditions

Interventions

DEVICE

Evoke Spinal Cord Stimulation (SCS) System

ECAP-controlled, closed-loop SCS

Sponsors & Collaborators

  • Saluda Medical Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Angela M Leitner · Saluda Medical Pty Ltd

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2027-01-01
Completion
2027-01-01

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04662905 on ClinicalTrials.gov